To include your compound in the COVID-19 Resource Center, submit it here.

Vector central in Pittsburgh

The University of Pittsburgh's Cardiovascular Gene Therapy Center has been designated as the only national facility for producing vectors for use in clinical trials funded by the

Read the full 272 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE